Skip to main content

Table 5 Cox regression analysis for main study outcomes

From: Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

 

Univariate

Multivariablea

 

HR (95% CI)

P

HR (95% CI)

P

Cardiovascular Events, n (%)

 Cluster 1

1.85 [1.46–2.34]

< .001

1.88 [1.48–2.38]

< .001

Cluster 2 (Ref.)

 Cluster 3

2.82 [2.24–3.55]

< .001

2.87 [2.27–3.62]

< .001

All-cause death, n (%)

 Cluster 1

2.55 [2.03–3.21]

< .001

2.50 [1.98–3.15]

< .001

Cluster 2 (Ref.)

 Cluster 3

3.55 [2.83–4.46]

< .001

3.42 [2.72–4.31]

< .001

Composite outcome, n (%)

 Cluster 1

2.09 [1.74–2.51]

< .001

2.09 [1.74–2.51]

< .001

Cluster 2 (Ref.)

 Cluster 3

2.81 [2.34–3.37]

< .001

2.79 [2.32–3.35]

< .001

  1. Legend: aadjusted for type of AF, EHRA score, use of OAC. HR hazard ratio. For other acronyms, please see previous tables’ legends